CIK 0001832038 · <br>Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851403134
- Phone
- (781) 819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,089
- in 5 filings, $177K under 10b5-1 plans
Net −$177,089. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Andersen Jill −$53K Chief Legal Officer, Secretary sold 19% of stake
- Duke William E. −$32K Chief Financial Officer sold 19% of stake
- Green Julie −$32K Chief Human Resources Officer sold 19% of stake
- Lee Timothy Edward −$32K Chief Commercial Officer sold 19% of stake
- Allen Robert D. III −$29K Chief Scientific Officer sold 17% of stake
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-19 | Allen Robert D. III Chief Scientific Officer | Sale 10b5-1 | −27,420 | $0.57 | $16K | 53,068 |
| 2025-08-18 | Lee Timothy Edward Chief Commercial Officer | Sale 10b5-1 | −20,013 | $0.65 | $13K | 88,987 |
| 2025-08-18 | Duke William E. Chief Financial Officer | Sale 10b5-1 | −20,013 | $0.65 | $13K | 78,987 |
| 2025-08-18 | Green Julie Chief Human Resources Officer | Sale 10b5-1 | −20,013 | $0.65 | $13K | 78,987 |
| 2025-08-18 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −33,352 | $0.65 | $22K | 133,848 |
| 2025-08-18 | Allen Robert D. III Chief Scientific Officer | Sale 10b5-1 | −18,512 | $0.65 | $12K | 80,488 |
| 2025-08-15 | Lee Timothy Edward Chief Commercial Officer | Option exercise 10b5-1 | +99,000 | 109,000 | ||
| 2025-08-15 | Lee Timothy Edward Chief Commercial Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 201,000 | ||
| 2025-08-15 | Duke William E. Chief Financial Officer | Option exercise 10b5-1 | +99,000 | 99,000 | ||
| 2025-08-15 | Duke William E. Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 201,000 | ||
| 2025-08-15 | Green Julie Chief Human Resources Officer | Option exercise 10b5-1 | +99,000 | 99,000 | ||
| 2025-08-15 | Green Julie Chief Human Resources Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 201,000 | ||
| 2025-08-15 | Andersen Jill Chief Legal Officer, Secretary | Option exercise 10b5-1 | +165,000 | 167,200 | ||
| 2025-08-15 | Andersen Jill Chief Legal Officer, Secretary | Option exercise · Restricted Stock Units 10b5-1 | −165,000 | 335,000 | ||
| 2025-08-15 | Allen Robert D. III Chief Scientific Officer | Option exercise 10b5-1 | +99,000 | 99,000 | ||
| 2025-08-15 | Allen Robert D. III Chief Scientific Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 201,000 | ||
| 2025-05-20 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-20 | Berry Tamsin Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-20 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-20 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 4 of 9 · 161 trades